Talha Ijaz1, Hong Sun1, Irina V Pinchuk1, Dianna M Milewicz1, Ronald G Tilton1, Allan R Brasier2. 1. From the Department of Biochemistry and Molecular Biology (T.I.), MD-PhD Program (T.I.), Division of Gasteroenterology, Department of Internal Medicine (I.V.P.), Division of Endocrinology, Department of Internal Medicine (H.S., R.G.T., A.R.B.), Institute for Translational Sciences (R.G.T., A.R.B.), Sealy Center for Molecular Medicine (R.G.T., A.R.B.), University of Texas Medical Branch, Galveston; and Department of Internal Medicine, University of Texas Health Science Center at Houston (D.M.M.). 2. From the Department of Biochemistry and Molecular Biology (T.I.), MD-PhD Program (T.I.), Division of Gasteroenterology, Department of Internal Medicine (I.V.P.), Division of Endocrinology, Department of Internal Medicine (H.S., R.G.T., A.R.B.), Institute for Translational Sciences (R.G.T., A.R.B.), Sealy Center for Molecular Medicine (R.G.T., A.R.B.), University of Texas Medical Branch, Galveston; and Department of Internal Medicine, University of Texas Health Science Center at Houston (D.M.M.). arbrasie@utmb.edu.
Abstract
OBJECTIVE: Infusion of angiotensin II (Ang II) induces extracellular matrix remodeling and inflammation resulting in abdominal aortic aneurysms (AAAs) in normolipidemic mice. Although Ang II activates mesenchymal cells in the media and adventitia to become fibrogenic, the sentinel role of this mesenchymal population in modulating the inflammatory response and aneurysms is not known. We test the hypothesis that these fibrogenic mesenchymal cells play a critical role in Ang II-induced aortic wall vascular inflammation and AAA formation. APPROACH AND RESULTS: Ang II infusion increased phospho-Ser536-RelA and interleukin (IL)-6 immunostaining in the abdominal aorta. In addition, aortic mRNA transcripts of RelA-dependent cytokines IL-6 and IL-1β were significantly elevated suggesting that Ang II functionally activates RelA signaling. To test the role of mesenchymal RelA in AAA formation, we generated RelA-CKO mice by administering tamoxifen to double transgenic mice harboring RelA-flox alleles and tamoxifen-inducible Col1a2 promoter-driven Cre recombinase (Col1a2-CreERT). Tamoxifen administration to Col1a2-CreERT•mT/mG mice induced Cre expression and RelA depletion in aortic smooth muscle cells and fibroblasts but not in endothelial cells. Infusion of Ang II significantly increased abdominal aortic diameter and the incidence of AAA in RelA wild-type but not in RelA-CKO mice, independent of changes in systolic blood pressure. Furthermore, mesenchymal cell-specific RelA-CKO mice exhibited decreased expression of IL-6 and IL-1β cytokines and decreased recruitment of C68+ and F4/80lo•Ly6Chi monocytes during Ang II infusion. CONCLUSIONS: Fibrogenic mesenchymal RelA plays a causal role in Ang II-induced vascular inflammation and AAA in normolipidemic mice.
OBJECTIVE: Infusion of angiotensin II (Ang II) induces extracellular matrix remodeling and inflammation resulting in abdominal aortic aneurysms (AAAs) in normolipidemic mice. Although Ang II activates mesenchymal cells in the media and adventitia to become fibrogenic, the sentinel role of this mesenchymal population in modulating the inflammatory response and aneurysms is not known. We test the hypothesis that these fibrogenic mesenchymal cells play a critical role in Ang II-induced aortic wall vascular inflammation and AAA formation. APPROACH AND RESULTS:Ang II infusion increased phospho-Ser536-RelA and interleukin (IL)-6 immunostaining in the abdominal aorta. In addition, aortic mRNA transcripts of RelA-dependent cytokines IL-6 and IL-1β were significantly elevated suggesting that Ang II functionally activates RelA signaling. To test the role of mesenchymal RelA in AAA formation, we generated RelA-CKOmice by administering tamoxifen to double transgenic mice harboring RelA-flox alleles and tamoxifen-inducible Col1a2 promoter-driven Cre recombinase (Col1a2-CreERT). Tamoxifen administration to Col1a2-CreERT•mT/mG mice induced Cre expression and RelA depletion in aortic smooth muscle cells and fibroblasts but not in endothelial cells. Infusion of Ang II significantly increased abdominal aortic diameter and the incidence of AAA in RelA wild-type but not in RelA-CKOmice, independent of changes in systolic blood pressure. Furthermore, mesenchymal cell-specific RelA-CKOmice exhibited decreased expression of IL-6 and IL-1β cytokines and decreased recruitment of C68+ and F4/80lo•Ly6Chi monocytes during Ang II infusion. CONCLUSIONS: Fibrogenic mesenchymal RelA plays a causal role in Ang II-induced vascular inflammation and AAA in normolipidemic mice.
Authors: Brian C Tieu; Xiaoxi Ju; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Allan R Brasier; Ronald G Tilton Journal: J Vasc Res Date: 2010-11-23 Impact factor: 1.934
Authors: William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi Journal: Arterioscler Thromb Vasc Biol Date: 2013-01-03 Impact factor: 8.311
Authors: Nathaniel M Weathington; Anneke H van Houwelingen; Brett D Noerager; Patricia L Jackson; Aletta D Kraneveld; F Shawn Galin; Gert Folkerts; Frans P Nijkamp; J Edwin Blalock Journal: Nat Med Date: 2006-02-12 Impact factor: 53.440
Authors: Alan Daugherty; Debra L Rateri; Israel F Charo; A Phillip Owens; Deborah A Howatt; Lisa A Cassis Journal: Clin Sci (Lond) Date: 2010-03-09 Impact factor: 6.124
Authors: Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312
Authors: Aaron C Petrey; Fares Qeadan; Elizabeth A Middleton; Irina V Pinchuk; Robert A Campbell; Ellen J Beswick Journal: J Leukoc Biol Date: 2020-09-15 Impact factor: 4.962
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Hisashi Sawada (澤田悠); Hong S Lu (吕红); Lisa A Cassis; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2022-01-20 Impact factor: 8.311